Search alternatives:
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly higher (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), levels decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 61 - 80 results of 7,076 for search '(( significantly longer decrease ) OR ( significantly ((less decrease) OR (we decrease)) ))', query time: 0.30s Refine Results
  1. 61
    Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection.

    Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. by Jeffrey Chin (22538086)

    Published 2025
    Save to List
    Saved in:
  2. 62
    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”
    Save to List
    Saved in:
  3. 63
    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”
    Save to List
    Saved in:
  4. 64
    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”
    Save to List
    Saved in:
  5. 65
    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”
    Save to List
    Saved in:
  6. 66
    Flowchart of included and excluded patients.

    Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Characteristics of the study group.

    Characteristics of the study group. by P.G.J. ter Horst (21743830)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    The linearly decreasing convergence factor a.

    The linearly decreasing convergence factor a. by Junhao Wei (6816803)

    Published 2025
    Save to List
    Saved in:
  9. 69
    Estimated variation in <i>R</i> <i><sub> t </sub></i> (%, and its 95% CI) associated with other driving factors when the mean of serial interval was assumed 2 or 5 days and the end of an epidemic was defined as decreasing for not less than 6-, 7- or 9-weeks using GAMs.

    Estimated variation in <i>R</i> <i><sub> t </sub></i> (%, and its 95% CI) associated with other driving factors when the mean of serial interval was assumed 2 or 5 days and the end... by Wanqi Wen (20896573)

    Published 2025
    Save to List
    Saved in:
  10. 70
    LDL-C meta-analysis showing in (A) the overall effects of different statin types versus placebo and (B) stratified by statin treatment duration for 3-4 months and longer than 4 months.

    LDL-C meta-analysis showing in (A) the overall effects of different statin types versus placebo and (B) stratified by statin treatment duration for 3-4 months and longer than 4 mon... by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Overall analysis of randomized controlled trials.

    Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Newcastle-Ottawa scale.

    Newcastle-Ottawa scale. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are displayed.

    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Save to List
    Saved in:
  14. 74
    Average Heart Rate across pre-interview, interview and post-interview phases for High and Low Clarity and Authority groups: Heart Rate (HR) increases from pre-interview to interview phase and decreases again in post-interview.

    Average Heart Rate across pre-interview, interview and post-interview phases for High and Low Clarity and Authority groups: Heart Rate (HR) increases from pre-interview to intervie... by David Vagni (8060432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Example of Group C scene material.

    Example of Group C scene material. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Conditional autonomous driving scenario complexity hierarchy.

    Conditional autonomous driving scenario complexity hierarchy. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Mean (SD) of fixation duration, fixation counts, and SAGAT accuracy according to scene complexity and autonomous driving information display type.

    Mean (SD) of fixation duration, fixation counts, and SAGAT accuracy according to scene complexity and autonomous driving information display type. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Point in time of the first visible deviation from the trail in each scenario.

    Point in time of the first visible deviation from the trail in each scenario. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Displays types of autonomous driving information: a) P3D display on the W-HUD; b) SR display on the W-HUD; c) display on the AR-HUD.

    Displays types of autonomous driving information: a) P3D display on the W-HUD; b) SR display on the W-HUD; c) display on the AR-HUD. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Experiment setting.

    Experiment setting. by Chengmin Zhou (14554562)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: